From pharmacovigilance to pharmacovigilance planning - The system building for safe medication

Hui Po Wang, Chun Li Wang, Wan Neng Yu, Shu Hui Hsu, Yu Wen Huang, Yu Ling Lin, Yen Lih Leu, Chin Yi Lee

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The concept of pharmacovigilance planning (PVP) was initiated by the International Conference on Harmonization (ICH) in 2004 and followed by the publication of Topic ICH E2E Guideline. However, the implementation of PVP in societies like Taiwan where irrational medication or co-medication of conventional medicine with complementary/alternative medicine (CAM) is prevalent, became a challenge. This report aimed to (1) introduce the concept of PVP and the importance of evidence-based justification of medicinal products for risk prevention and minimization, (2) summarize the scientific evidence regarding the sites and mechanisms of drug-drug or drug-CAM interactions along the biological processing of xenobiotics and identify potential risks in relation to co-medication of conventional medicine with CAM by reviewing literatures, (3) employ public information to analyze potential risk underlying irrational medication of registered medicine, registered traditional Chinese medicine (TCM) and un-registered CAM in Taiwan, and (4) address the importance of conceptual change from individual product-oriented pharmacovigilance to a proactive system-based risk management of pharmacovigilance planning.

Original languageEnglish
Pages (from-to)377-386
Number of pages10
JournalJournal of Food and Drug Analysis
Volume15
Issue number4
Publication statusPublished - Dec 2007

Fingerprint

Pharmacovigilance
alternative medicine
Complementary Therapies
drug therapy
planning
medicine
drugs
Taiwan
risk management
Medicine
xenobiotics
traditional medicine
Pharmaceutical Preparations
Chinese Traditional Medicine
Risk Management
Xenobiotics
Publications
Guidelines

Keywords

  • Co-medication
  • Complementary/alternativemedicine (CAM)
  • Conventional medicine
  • Medication risk
  • Nutraceuticals
  • Pharmacovigilance planning
  • Safe medication
  • Traditional Chinese medicine (TCM)
  • Xenobiotics

ASJC Scopus subject areas

  • Food Science
  • Pharmacology

Cite this

Wang, H. P., Wang, C. L., Yu, W. N., Hsu, S. H., Huang, Y. W., Lin, Y. L., ... Lee, C. Y. (2007). From pharmacovigilance to pharmacovigilance planning - The system building for safe medication. Journal of Food and Drug Analysis, 15(4), 377-386.

From pharmacovigilance to pharmacovigilance planning - The system building for safe medication. / Wang, Hui Po; Wang, Chun Li; Yu, Wan Neng; Hsu, Shu Hui; Huang, Yu Wen; Lin, Yu Ling; Leu, Yen Lih; Lee, Chin Yi.

In: Journal of Food and Drug Analysis, Vol. 15, No. 4, 12.2007, p. 377-386.

Research output: Contribution to journalArticle

Wang, HP, Wang, CL, Yu, WN, Hsu, SH, Huang, YW, Lin, YL, Leu, YL & Lee, CY 2007, 'From pharmacovigilance to pharmacovigilance planning - The system building for safe medication', Journal of Food and Drug Analysis, vol. 15, no. 4, pp. 377-386.
Wang, Hui Po ; Wang, Chun Li ; Yu, Wan Neng ; Hsu, Shu Hui ; Huang, Yu Wen ; Lin, Yu Ling ; Leu, Yen Lih ; Lee, Chin Yi. / From pharmacovigilance to pharmacovigilance planning - The system building for safe medication. In: Journal of Food and Drug Analysis. 2007 ; Vol. 15, No. 4. pp. 377-386.
@article{44b4ec0509514d569b57a3c7412479dc,
title = "From pharmacovigilance to pharmacovigilance planning - The system building for safe medication",
abstract = "The concept of pharmacovigilance planning (PVP) was initiated by the International Conference on Harmonization (ICH) in 2004 and followed by the publication of Topic ICH E2E Guideline. However, the implementation of PVP in societies like Taiwan where irrational medication or co-medication of conventional medicine with complementary/alternative medicine (CAM) is prevalent, became a challenge. This report aimed to (1) introduce the concept of PVP and the importance of evidence-based justification of medicinal products for risk prevention and minimization, (2) summarize the scientific evidence regarding the sites and mechanisms of drug-drug or drug-CAM interactions along the biological processing of xenobiotics and identify potential risks in relation to co-medication of conventional medicine with CAM by reviewing literatures, (3) employ public information to analyze potential risk underlying irrational medication of registered medicine, registered traditional Chinese medicine (TCM) and un-registered CAM in Taiwan, and (4) address the importance of conceptual change from individual product-oriented pharmacovigilance to a proactive system-based risk management of pharmacovigilance planning.",
keywords = "Co-medication, Complementary/alternativemedicine (CAM), Conventional medicine, Medication risk, Nutraceuticals, Pharmacovigilance planning, Safe medication, Traditional Chinese medicine (TCM), Xenobiotics",
author = "Wang, {Hui Po} and Wang, {Chun Li} and Yu, {Wan Neng} and Hsu, {Shu Hui} and Huang, {Yu Wen} and Lin, {Yu Ling} and Leu, {Yen Lih} and Lee, {Chin Yi}",
year = "2007",
month = "12",
language = "English",
volume = "15",
pages = "377--386",
journal = "Journal of Food and Drug Analysis",
issn = "1021-9498",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - From pharmacovigilance to pharmacovigilance planning - The system building for safe medication

AU - Wang, Hui Po

AU - Wang, Chun Li

AU - Yu, Wan Neng

AU - Hsu, Shu Hui

AU - Huang, Yu Wen

AU - Lin, Yu Ling

AU - Leu, Yen Lih

AU - Lee, Chin Yi

PY - 2007/12

Y1 - 2007/12

N2 - The concept of pharmacovigilance planning (PVP) was initiated by the International Conference on Harmonization (ICH) in 2004 and followed by the publication of Topic ICH E2E Guideline. However, the implementation of PVP in societies like Taiwan where irrational medication or co-medication of conventional medicine with complementary/alternative medicine (CAM) is prevalent, became a challenge. This report aimed to (1) introduce the concept of PVP and the importance of evidence-based justification of medicinal products for risk prevention and minimization, (2) summarize the scientific evidence regarding the sites and mechanisms of drug-drug or drug-CAM interactions along the biological processing of xenobiotics and identify potential risks in relation to co-medication of conventional medicine with CAM by reviewing literatures, (3) employ public information to analyze potential risk underlying irrational medication of registered medicine, registered traditional Chinese medicine (TCM) and un-registered CAM in Taiwan, and (4) address the importance of conceptual change from individual product-oriented pharmacovigilance to a proactive system-based risk management of pharmacovigilance planning.

AB - The concept of pharmacovigilance planning (PVP) was initiated by the International Conference on Harmonization (ICH) in 2004 and followed by the publication of Topic ICH E2E Guideline. However, the implementation of PVP in societies like Taiwan where irrational medication or co-medication of conventional medicine with complementary/alternative medicine (CAM) is prevalent, became a challenge. This report aimed to (1) introduce the concept of PVP and the importance of evidence-based justification of medicinal products for risk prevention and minimization, (2) summarize the scientific evidence regarding the sites and mechanisms of drug-drug or drug-CAM interactions along the biological processing of xenobiotics and identify potential risks in relation to co-medication of conventional medicine with CAM by reviewing literatures, (3) employ public information to analyze potential risk underlying irrational medication of registered medicine, registered traditional Chinese medicine (TCM) and un-registered CAM in Taiwan, and (4) address the importance of conceptual change from individual product-oriented pharmacovigilance to a proactive system-based risk management of pharmacovigilance planning.

KW - Co-medication

KW - Complementary/alternativemedicine (CAM)

KW - Conventional medicine

KW - Medication risk

KW - Nutraceuticals

KW - Pharmacovigilance planning

KW - Safe medication

KW - Traditional Chinese medicine (TCM)

KW - Xenobiotics

UR - http://www.scopus.com/inward/record.url?scp=40749130000&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749130000&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:40749130000

VL - 15

SP - 377

EP - 386

JO - Journal of Food and Drug Analysis

JF - Journal of Food and Drug Analysis

SN - 1021-9498

IS - 4

ER -